on Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Protagonist Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
Newark, CA / ACCESSWIRE / September 3, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) announced that CEO Dinesh V. Patel, Ph.D., will engage in a fireside chat and one-on-one meetings at the H.C. Wainwright 26th Annual Global Investment Conference in New York, NY. The event will occur from September 9-11, 2024.
The fireside chat is scheduled for Tuesday, September 10, at 1:30 P.M. ET and can be viewed via webcast. Interested parties are encouraged to contact their H.C. Wainwright representative to arrange meetings with the Protagonist team during the conference.
For more details on their pipeline drug candidates and ongoing clinical studies, visit www.protagonist-inc.com.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Protagonist Therapeutics, Inc. news